Healthcare provider profile · identity verified

Jordan Collier, MD

Internal Medicine · NEW ROCHELLE, NY · NPI 1376861740

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	340	54
Levothyroxine Sodium	Levothyroxine Sodium	272	30
Amlodipine Besylate	Amlodipine Besylate	240	40
Eliquis	Apixaban	207	22
Furosemide	Furosemide	163	21
Metoprolol Succinate	Metoprolol Succinate	143	24
Sertraline Hcl	Sertraline Hcl	127	21
Trazodone Hcl	Trazodone Hcl	121	17
Lisinopril	Lisinopril	118	19
Potassium Chloride	Potassium Chloride	117	17
Gabapentin	Gabapentin	109	19
Pantoprazole Sodium	Pantoprazole Sodium	108	26
Mirtazapine	Mirtazapine	101	15
Carvedilol	Carvedilol	91	16
Metoprolol Tartrate	Metoprolol Tartrate	91	17
Tamsulosin Hcl	Tamsulosin Hcl	78	16
Omeprazole	Omeprazole	74	12
Quetiapine Fumarate	Quetiapine Fumarate	74	suppressed
Midodrine Hcl	Midodrine Hcl	73	15
Alprazolam	Alprazolam	70	suppressed
Levetiracetam	Levetiracetam	67	13
Famotidine	Famotidine	65	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	suppressed
Novolog Flexpen	Insulin Aspart	59	suppressed
Xarelto	Rivaroxaban	59	suppressed
Simvastatin	Simvastatin	57	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	12
Oxycodone Hcl	Oxycodone Hcl	54	16
Lorazepam	Lorazepam	52	13
Donepezil Hcl	Donepezil Hcl	51	suppressed
Latanoprost	Latanoprost	48	suppressed
Clonazepam	Clonazepam	45	suppressed
Metformin Hcl	Metformin Hcl	44	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	43	14
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Albuterol Sulfate	Albuterol Sulfate	41	17
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Risperidone	Risperidone	40	suppressed
Losartan Potassium	Losartan Potassium	39	suppressed
Scopolamine	Scopolamine	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Lansoprazole	Lansoprazole	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	12
Ezetimibe	Ezetimibe	32	suppressed
Haloperidol	Haloperidol	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Prednisone	Prednisone	31	suppressed
Baclofen	Baclofen	30	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Lacosamide	Lacosamide	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Budesonide	Budesonide	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Restasis	Cyclosporine	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Morphine Sulfate	Morphine Sulfate	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Sodium Bicarbonate	Sodium Bicarbonate	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Enulose	Lactulose	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Finasteride	Finasteride	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Acetylcysteine	Acetylcysteine	13	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Lactulose	Lactulose	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Valsartan	Valsartan	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Sodium Chloride	0.9 % Sodium Chloride	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error